BNP Paribas Financial Markets’s Soleno Therapeutics SLNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299K | Buy |
3,567
+2,331
| +189% | +$195K | ﹤0.01% | 2816 |
|
|
2025
Q1 | $88.3K | Sell |
1,236
-70,084
| -98% | -$5.01M | ﹤0.01% | 3251 |
|
|
2024
Q4 | $3.21M | Buy |
+71,320
| New | +$3.21M | ﹤0.01% | 1438 |
|
|
2022
Q4 | – | Sell |
-9,333
| Closed | -$15.6K | – | 3821 |
|
|
2022
Q3 | $15.6K | Sell |
9,333
-2
| -0% | -$3 | ﹤0.01% | 3418 |
|
|
2022
Q2 | $25.9K | Hold |
9,335
| – | – | ﹤0.01% | 3032 |
|
|
2022
Q1 | $31.2K | Sell |
9,335
-11
| -0.1% | -$37 | ﹤0.01% | 3081 |
|
|
2021
Q4 | $57.5K | Sell |
9,346
-10
| -0.1% | -$61 | ﹤0.01% | 3076 |
|
|
2021
Q3 | $130K | Buy |
9,356
+5
| +0.1% | +$69 | ﹤0.01% | 2599 |
|
|
2021
Q2 | $160K | Sell |
9,351
-544
| -5% | -$9.3K | ﹤0.01% | 2333 |
|
|
2021
Q1 | $187K | Sell |
9,895
-126
| -1% | -$2.38K | ﹤0.01% | 2524 |
|
|
2020
Q4 | $290K | Sell |
10,021
-170
| -2% | -$4.92K | ﹤0.01% | 2086 |
|
|
2020
Q3 | $384K | Buy |
10,191
+780
| +8% | +$29.4K | ﹤0.01% | 1797 |
|
|
2020
Q2 | $313K | Buy |
9,411
+83
| +0.9% | +$2.76K | ﹤0.01% | 1710 |
|
|
2020
Q1 | $333K | Buy |
+9,328
| New | +$333K | ﹤0.01% | 2011 |
|